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ABSTRACT 
 
Introduction : Cardiovascular  diseases are the leading cause of premature death in our 
country. Among the risk factors for cardiovascular diseases are prehypertension and 
smoking. Up to date there was no study looking for associated factors for 
prehypertension among smokers.  
 
Objective : To determine the prevalence of prehypertension and its associated factors 
among smokers attending Klinik Kesihatan Bandar Kota Bharu. 
 
Methodology : A cross sectional study involving a total of 333 current smokers aged 
more than 18 years at Klinik Kesihatan Bandar Kota Bharu from January to April 2017 
by using convenient sampling. Respondents answered a questionnaire consists of socio-
demographic back ground, IPAQ-M, MyNCDs – dietary assessment  and FTND-M  and 
followed with physical  measurements for BP,weight, height and waist circumference. 
Data was analysed using descriptive analysis and logistic regression. 
 
Result :  The mean (SD) age of respondents was 32.6 (10.3) and 57.7% (192) of current 
smokers have prehypertension. Through multivariate analysis using multiple logistic 
regression test, this study showed age ( adjusted OR=1.03,95% CI 1.00, 1.05,p=0.020), 
BMI ( adjusted OR=1.1195% CI 1.03,1.20,p=0.006), family history of hypertension 
(adjusted OR=1,78,95% CI 1.04,2.71,p=0.034), unhealthy diet (adjusted OR= 4.48,95% 
CI 1.88,10.63,p=0.001) and central obesity (adjusted OR=2.68,95% CI 
1.22,5.89,p=0.014) were the associated factors for prehypertension. 
xi 
 
Conclusion : Prehypertension is common among current smokers and associated with 
many factors. Lifestyle modifications need to be given to reduce the incidence of 
prehypertension and prevent from progressing to hypertension and cardiovascular 
disease. 
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ABSTRAK 
 
Pengenalan : Penyakit kardiovaskular adalah penyebab utama kematian awal dalam 
kalangan rakyat Malaysia. Prahipertensi dan merokok adalah faktor-faktor  risiko 
kepada penyakit kardiovaskular. Setakat ini tiada lagi kajian dijalankan untuk 
mengetahui faktor-faktor yang mengaitkan prahipertensi dengan merokok. 
 
Objektif : Untuk menentukan peratusan prahipertensi dan faktor –faktor yang berkaitan 
di kalangan perokok semasa yang hadir ke Klinik Kesihatan Bandar Kota Bharu. 
 
Metodologi : Sebuah kajian keratan rentas melibatkan 333 perokok semasa yang 
berumur 18 tahun dan ke atas yang hadir ke Klinik Kesihatan Bandar Kota Bharu pada 
bulan Januari hingga April 2017. Perokok semasa dipilih menggunakan proses 
persampelan mudah. Kajian telah dijalankan dengan menggunakan borang kaji selidik 
yang mengandungi maklumat latar belakang, IPAQ-M, MyNCDs – penilaian diet dan 
FTND-M  serta pengambilan tekanan darah, ukuran berat, tinggi dan lilit pinggang. 
Data telah dianalisa  dengan statistik deskriptif dan regresi logistik . 
 
Keputusan : Umur min (SD) adalah 32.6 (10.3) tahun dan 57.7% (192) daripada 
perokok semasa mempunyai masalah prahipertensi. Melalui analisa regresi logistik 
berganda, didapati  umur (OR=1.03,95% CI 1.00, 1.05,p=0.020), jisim berat badan 
(OR=1.1195% CI 1.03,1.20,p=0.006), sejarah darah tinggi dalam keluarga  
(OR=1,78,95%CI1.04,2.71,p=0.034), diet tidak sihat (OR= 4.48,95% CI 
1.88,10.63,p=0.001) dan obesiti pusat ( OR=2.68,95% CI 1.22,5.89,p=0.014) adalah 
faktor-faktor yang mengaitkan prahipertensi dan merokok. 
xiii 
 
 
Kesimpulan : Secara amnya, masalah prahipertensi dalam kalangan perokok adalah 
tinggi dan faktor – faktor yang berkaitan adalah banyak. Pengubahsuaian gaya hidup ke 
arah cara hidup sihat perlu di terapkan untuk mengurangkan kejadian prahipertensi dan 
mencegah  sebelum menjadi hipertensi dan penyakit kardiovaskular. 
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CHAPTER ONE : INTRODUCTION 
 
In the era of 21
st
 century, non-communicable diseases (NCD) are one of the important  
health challenges affecting the population. It is a major cause of human sufferings hence 
affecting the socio-economic of the inflicted country.  
World Health Organization (WHO) had released second global status report on non- 
communicable disease in 2014. The report showed 38 million deaths out of total 56 
million were due to NCDs and the leading cause for that premature death was 
cardiovascular diseases, (17.5 million deaths, or 46.2% of NCDs death).Furthermore, 
total number of death due to NCDs are projected to increase to 52 million by year 2030 
(WHO, 2014a) 
According to Malaysia’s 2014 NCD profile that was released from WHO, an estimated 
73% of total death in our country were contributed by death from NCD which major 
cause was cardiovascular diseases. A worrying 35% of this group is  premature death of 
our working population who are individuals aged less than 60 years old (WHO, 2014b). 
 Data published by the Institute for Public Health on The Second Burden of Disease 
Study for Malaysia showed that hypertension, smoking, diabetes, high cholesterol and 
high body mass index (BMI) were the biggest contributors for disability adjusted life-
years (DALY) and deaths (MOH, 2015). Furthermore, Framingham Heart Study also 
reported among the classical factors for cardiovascular diseases were hypertension, 
hyperlipidaemia, smoking, diabetes mellitus, physical inactivity and obesity (O'Donnell 
and Elosua, 2008). 
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JNC defined prehypertension as a systolic blood pressure (SBP) of 120 to 139 mmHg or 
a diastolic blood pressure (DBP) of 80 to 89 mmHg in adults 18 years and older. Studies 
have shown that people with prehypertension are at risk for progression towards 
hypertension and due to the fact that prehypertension itself as an independent 
cardiovascular disease risk factor (Chobanian et al., 2003). 
In Malaysia, the comparison between prehypertension and hypertension is apparent 
when the data from National Health and Morbidity Survey 2006 (NHMS III) revealed 
that  prehypertension prevails more among our adult population at 37%, higher than 
prevalence of hypertension which was 32.2% (MOH, 2008). The latest available data 
reported by Salmiah et al. She noted that the prevalence of prehypertension in Malaysia 
among public university students was 34.1% (Salmiah et al., 2014).  
Cigarette smoking is another well documented risk factor for cardiovascular disease. 
For the past three decades, smoking related diseases such as cancer and cardiovascular 
diseases remain the main causes of premature death in Malaysia. Every year, 20 000 
Malaysians were killed because of smoking and if this smoking habit does  not improve 
then the figure will increase to 30 000 by the year 2020 (MOH, 2016). In Latest 
National Health and Morbidity Survey 2015, current smokers amounted to 22.8%, of 
the respondents and statistic showed a decrease compared to National Health Morbidity 
Survey in 2011. This means in 2015, there were nearly five million Malaysians aged 15 
years and above who smoke (MOH, 2015). 
Many had done studies in determining the associated factors for prehypertension among 
general population. Risk factors including weight, dyslipidaemia and impaired glucose 
metabolism were observed. In regard to prehypertension, the association between 
prehypertension and smoking still remain unclear. However, multiple prospective 
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studies have consistently shown that cigarette smoking is associated with increased risk 
for hypertension (Dochi et al., 2009; Halperin et al., 2008). By considering smoking 
itself an independent risk factor for cardiovascular disease and smokers also at risk for 
hypertension, study on prehypertension among smokers are thus required.  
As concurrent risk factors, the risk for cardiovascular disease increased in multiplicative 
rather than additive fashion (Vander Weg et al., 2008). In view of prehypertension as a 
precursor for hypertension and an independent risk factor for cardiovascular disease, the 
same result is expected. So far there are not many studies looking specifically on 
associated factors for prehypertension among smokers.  
We are hoping by doing this study, it will help in in evaluating association of smoking 
and prehypertension hence recognizing other risk factors that would relate smokers to 
prehypertension. By knowing the associated factors, early intervention could be taken to 
prevent them from progressing to hypertension and cardiovascular disease which could 
spare them the related morbidity and mortality. Studies have shown earlier preventative 
efforts were effective in delaying or preventing the onset of hypertension (Gupta et al., 
2011; Gupta et al., 2010).  
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CHAPTER TWO: LITERATURE REVIEW 
 
2.1  Prevalence of prehypertension. 
Since JNC 7 introduced the new prehypertension classification in 2003, the prevalence 
of prehypertension and its associated risk factors has been investigated worldwide. The 
Malaysian Clinical Practice Guidelines Management of Hypertension (4
th
 Edition) has 
also adopted this definition (MOH, 2014). Multiple studies have shown that prevalence 
of prehypertension in general population are varied in a very wide range across the 
countries (Aekplakorn et al., 2008; Wang and Wang, 2004; Xu et al., 2016)   
In the US, data collected from 4805 respondents age 18 years and older in the 1999 -
2000 National Health and Nutrition Examination Survey showed 31% of them were 
prehypertensive (Wang and Wang, 2004). This percentage was almost similar to 
findings  of the same study made in a few other countries whereby it was 33%  in Japan 
(Ishikawa et al., 2008), 32.8% in Netherland (Agyemang et al., 2007), 32.3% in India 
(Yadav et al., 2008)  and 32.8% in Thailand (Aekplakorn et al., 2008). However,  a 
study done in Nigeria showed a high prevalence of prehypertension, at about 58.7% 
(Isezuo et al., 2011) and the same was in Iran,52.1% (Janghorbani et al., 2008)  and 
China, 54.6 (Yang et al., 2010). However, a stark difference is revealed  in a study from 
Turkey which  shown low prevalence of prehypertension, at about 14.5% (Erem et al., 
2009). 
In Malaysia, the prevalence of prehypertension in adult population aged 18 and above in 
2006 was about 37%(MOH, 2008). A study done in 2010 by Hassan and colleague 
among 290 subjects in Raub, Pahang showed prevalence of prehypertension was 33% 
(Hassan et al., 2012). On the other hand, a  study on cardiovascular risk among 
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University Malaysia Sarawak undergraduate students showed 42.9 % out of 237 
students were prehypertensive (Lee et al., 2010). 
2.1.1 Cardiovascular disease and prehypertension 
Patients with prehypertension are susceptible to an increased risk for progression to 
hypertension. Vasan and colleague had demonstrated in the Framingham Heart Study, 
the high normal BP group (130-139/85-89) conversion rate to hypertension in 4 years 
was 37% (Vasan et al., 2001). Trial of Preventing Hypertension (TROPHY) study had 
in fact discovered an even higher conversion rate in which over a period of 4 years, 
stage 1 hypertension developed in two thirds of untreated prehypertensive patient 
(Julius et al., 2006).  
The relationship between BP vulnerability towards cardiovascular events is continuous, 
consistent and independent of other risk factors. The chance for myocardial infarction, 
heart failure, stroke and kidney disease are greater with higher BP level. For individual 
aged 40 to 70 years, every increment of 20 mmHg in SBP or 10 mmHg in DBP doubles 
the risk of CVD across the entire BP range from 115/75 to 185/115.It has been shown 
that almost a third of BP-related deaths from coronary heart disease occur in individuals 
with SBP between 110 – 139 (Lewington S, 2002). 
On top of that, a few studies demonstrated that prehypertension tends to come into 
cluster with other CVD risk factors such as glucose abnormalities, dyslipidaemia and 
obesity (Greenlund et al., 2004; Grotto et al., 2006; Kanauchi et al., 2004). Evidence 
has shown that prehypertension itself is and independent CVD risk factor (Kanauchi et 
al., 2004; Zhang et al., 2006). 
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2.2. Cigarette smoking and prehypertension 
Multiple studies have approvingly documented cigarette smoking is associated with 
increased risk of hypertension. Dochi and colleague had conducted a 14 year 
longitudinal study among Japanese male workers at a steel company between 1991 and 
2005. The result was positive on smoking being independently related to the onset of 
hypertension and systolic hypertension in Japanese male workers (Dochi et al., 2009). 
Other study by Niskanen et al and Halperin et al resulted in similar association 
(Halperin et al., 2008; Niskanen et al., 2004). 
Multiple factors had been postulated for development of hypertension with cigarette 
smoking. Research has shown cigarette smoking can stimulate oxidative stress (Burke 
and FitzGerald, 2003), sympathetic nervous activation (Narkiewicz et al., 1998), 
vasopressor effect (Barutcu et al., 2004), vascular inflammation and injury (Sharrett et 
al., 2006), endothelial dysfunction (Li et al., 2005) and increase in arterial stiffness 
(Narkiewicz et al., 2005). All the aforementioned  elements contribute to the aetiology 
of hypertension (Oparil et al., 2003; Sesso et al., 2003).  
Since prehypertension is a precursor for hypertension, the same association of smoking 
with hypertension was expected. However, studies have shown that the association 
between smoking and prehypertension still remain unclear. A study in Kunming, China 
showed heavy smokers was significantly associated with prehypertension (Cheng et al., 
2015). However, Gupta V et al (Gupta et al., 2013b) and Grotto et al (Grotto et al., 
2006) found no significant association between smoking and prehypertension. 
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2.2.1  Prehypertension among cigarette smoker 
Throughout this literature research, there is not much articles on the study of 
prehypertension prevalence among cigarette smokers. In the CHPSNE Study by Meng 
XJ, prevalence of prehypertension among current cigarette smokers in urban adults 
from 33 communities in China was 32.7% (Meng et al., 2012) similar to a study in 
Taiwan which showed almost same prevalence, 31.9% (Lin et al., 2010).  This shows 
prevalence of prehypertension among cigarette smokers is not much different in 
prevalence of prehypertension among general population. Nevertheless, a study among 
our public university students showed slightly higher prevalence that was 45% (Salmiah 
et al., 2014).So another study was required to ascertain the prevalence of 
prehypertension especially among smokers in our population. 
 
2.3  Risk factors for prehypertension  
From this literature review, it seems like there was no study found looking into factors 
that associated with prehypertension among smokers. Most of the studies were looking 
into associated risk factors for prehypertension in general population.  
The risk factors for prehypertension can be classified into two groups of factors, 
modifiable and non-modifiable. Age, gender, race and history of hypertension in first 
degree family members are considered non modifiable. Body mass index (BMI), waist 
circumference (WC), diabetes, dyslipidaemia, dietary factor, physical inactivity, alcohol 
consumption and smoking characteristic are considered modifiable. 
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2.3.1 Age 
Cross sectional surveys and prospective observational cohort studies have consistently 
showed a positive relation between age and blood pressure in most populations 
regardless geographical, cultural and socioeconomic characteristics (WHO, 1996). A 
study by Meng XJ discovered  people aged older than 18-34 years, suffered higher risk 
of getting prehypertension and the odds of getting prehypertension higher with 
increasing age (Meng et al., 2012). Esam et al showed mean systolic  and diastolic 
blood pressure increased steadily with increased in age (Esam and Husain). 
 
2.3.2 Gender 
Sexual differences in the distribution of prehypertension and hypertension apparently 
exist. Meta-analysis of 20 cross sectional and 6 longitudinal studies on epidemiology 
and risk factors for prehypertension showed pool prevalence of prehypertension among 
males much higher compared to female (Guo et al., 2011). This finding was similar to a 
study on hypertension in Korea, where the prevalence in men was also higher than 
women (Jo et al., 2001). Furthermore, Gupta et al demonstrated men have  higher 
prevalence of prehypertension and gender was significantly associated with 
development of prehypertension and hypertension (Gupta et al., 2013b). 
 
2.3.3 Race 
In NHMS 2015, prevalence of hypertension was highest among Other Bumiputras about 
33.4%, followed by Indians  at 32.4%, Malay at 31.1% and lastly Chinese at 30.8% 
(MOH, 2015). A study in Singapore that look at risk factors for prehypertension in three 
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Asian groups produced a different results with  prevalence of prehypertension among 
Malay was highest at about 68.9%, followed by Chinese at 58.9% and lastly Indian at 
57.7% (Chiang et al., 2013). 
 
2.3.4 Family history of hypertension 
Genetics contribute to the development of prehypertension and hypertension. A study in 
India among healthy young females showed significant association between family 
history of hypertension in first degree relatives with prehypertension (Chaudhry et al., 
2012). Xu et al also demonstrated subjects with positive family history had higher risk 
for prehypertension (Xu et al., 2016). 
 
2.3.5 Body Mass Index and Waist Circumference 
Higher body mass indices and waist circumferences were found in individuals with 
prehypertension compared to individuals with normotension, with waist circumferences 
showed greater relative differences. A meta-analysis of 24 case control studies in China 
reported that being overweight is an important risk factor for prehypertension (Guo et 
al., 2011). 
From the series of NHMS in our country, overweight, obesity and central obesity 
showed increasing trend among Malaysians. The prevalence of overweight and obesity 
among our adult aged ≥ 18 (2006, 2011, 2015) demonstrated 29.1%, 29.4% and 30.0% 
for overweight and 14.2%, 15.1% and 17.7% for obesity respectively (MOH, 2008; 
MOH, 2011; MOH, 2015)  
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The prevalence of central obesity among our adult aged ≥ 18 showed similar increasing 
trend from 17.4% in 2006 to 48.6% in 2015(MOH, 2008; MOH, 2015). The central 
obesity prevalence in our population was higher compared to world prevalence. This 
shows that our adult population are very at risk of prehypertension, looking at the 
increasing prevalence of overweight, obesity and central obesity in our country. 
 
2.3.6 Dietary factor 
American Heart Association has listed specific dietary component with scientific proofs 
for their effect on blood pressure. Among them are salt and alcohol that increases the 
BP while potassium and omega -3 fatty acids lower the BP. Other than that, body 
weight is also strongly related to blood pressure and  Dietary Approaches to Stop 
Hypertension (DASH) and a vegetarian diet are considered to lower the BP (Appel, 
2009; Karanja et al., 2007; Pickering, 2006).    
WHO STEPwise approach to non-communicable disease risk factor surveillance 
divided unhealthy diet into two components – low fruit and vegetable intake and diet 
high in salt (WHO, 2017). Listed below is the table showing the summarized 
recommendations on diet related lifestyle in lowering blood pressure by JNC 7. 
 
Table 1 : Lifestyle modifications to manage hypertension (Chobanian et al., 2003) 
Modification Recommendation SBP reduction 
(mmHg) 
Weight reduction Maintain normal body weight (BMI 18.5 – 
24.9kg/m²) 
5 – 20/10kg 
weight loss 
11 
 
DASH eating plan Consume a diet rich in fruits, vegetables and 
low fat dairy products 
8 - 14 
Dietary sodium 
reduction 
Not more than 2.4g Na/ 6g NaCl 2 - 8 
Physical activity Regular aerobic activity such as brisk walking 
(at least 30 minutes/day, most days in a week) 
4 - 9 
Alcohol ≤ 2 units/day (men), ≤ 1 unit/day (women) 2 - 4 
 
2.3.7  Physical activity 
Physical inactivity has been identified as a risk factor for raised blood pressure, raised 
blood sugar and overweight (WHO, 2010). A study on prevalence and risk factors for 
prehypertension in five Indian cities showed strong associations between sedentary 
lifestyle and prehypertension (SIngh et al., 2011). In support, a  meta-analysis on 35 
human clinical training studies demonstrated physical training reduced blood pressure 
in normotensive people (Kelley and Tran, 1995). 
Study also shown hypertensive subjects in aerobic exercise group reduced both SBP and 
DBP by 4.7mmHg and DBP respectively compared with non-exercise group subjects. 
Similar study also revealed aerobic exercise more effective than resistance type of 
exercise like weight lifting (Halbert et al., 1997). 
 
2.3.8 Alcohol consumption 
A close association between alcohol consumption and hypertension have been 
established through epidemiological and experimental investigations. Some studies  
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have recorded a linear-dose response relationship and other studies showed ingestion of 
smaller quantities of alcohol may reduce blood pressure (Fuchs et al., 2001; Gillman et 
al., 1995).  
A meta-analysis on alcohol and blood pressure by Lina Chen and colleague showed 
alcohol intake increased blood pressure even among moderate drinkers (Chen et al., 
2008).However,  a  meta-analysis on prehypertension showed unclear association 
between alcohol and prehypertension (Guo et al., 2011).  
 
2.3.9 Smoking characteristics 
Cigarette smoking caused direct inhalations of nicotine, tar products, nitric oxide-
derived free radicals, carbon monoxide and numerous other chemicals. All this 
chemicals induced promotion of atherogenesis, unfavourably changed lipid profile, 
increased blood viscosity, alters platelet function, promotes thrombosis and enhance 
adrenergic activity (Barutcu et al., 2004). 
Among the component in cigarette smoke, nicotine is the most studied component. 
Nicotine is well known addictive substance in cigarette smoke, it also plays a major role 
in smoking-related increases in cardiac output, heart rate and blood pressure by 
stimulate the body to produce adrenaline. Due to its addictive qualities, it likely 
perpetuate exposure to other more detrimental components in cigarette smoke (Ambrose 
and Barua, 2004). 
 Inhaled nicotine from cigarette smoking is metabolized to cotinine in liver and finally 
excreted in urine as the major nicotine metabolite. A study by Alshaarawy and 
colleague demonstrated second hand smokers with higher levels of serum cotinine were 
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positively associated with prehypertension independent of cofounders (Alshaarawy et 
al., 2013).  
Studies have reported number of cigarettes smoked per day is associated with 
hypertension (Cheng et al., 2015; Liu et al., 2013).  Liu T and colleague demonstrated 
that smokers consuming more than 15 cigarettes per day significantly increased the risk 
for hypertension (Liu et al., 2013). This is supported  by a study among male factory 
workers in Kunming, China showed heavy smoker (> 20 cigarettes/day) is associated 
with prehypertension and they were more dependent on nicotine than others (Cheng et 
al., 2015).   
A study in Vietnam showed those who had smoked for 30 years or more and those who 
smoked 20 pack-years or more were at higher risk for hypertension compared to those 
who never smoke. However, same study also showed current smokers were not at 
higher risk of hypertension than never smokers (Thuy et al., 2010). 
 
2.3.10  Impaired glucose tolerance and diabetes 
A meta-analysis by Guo et al looked into association between fasting plasma glucose 
and prehypertension found significant association between both (Guo et al., 2011). This 
was proved by Yadav et al showed subjects with prehypertension had higher prevalence 
of impaired glucose tolerance and diabetes compared to normotensive subject (Yadav et 
al., 2008).    
Greenlund et al reported that subjects with prehypertension were 1.65 times likely to 
have one other adverse cardiovascular risk factor (Greenlund et al., 2004). Due to fund 
limitation, this factor was not included in the study. 
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2.3.10  Dyslipidaemia 
Multiple studies have shown the significant association between dyslipidaemia with 
prehypertension (Agyemang et al., 2007; Gupta et al., 2013b; Ishikawa et al., 2008). 
SUNSET study on Dutch population showed higher cholesterol level in prehypertensive 
subjects and total cholesterol was independently associated with prehypertension 
(Agyemang et al., 2007). 
A meta-analysis on prehypertension showed total cholesterol and LDL-C were 
significantly associated with prehypertension and HDL-C was shown as a protective 
factor (Guo et al., 2011). However, it is not included in the study due to limitation of 
budget. 
 
2.4 Measuring tools and instruments 
There are various methods or tools in assessing specific associated factors for 
prehypertension. 
 
2.4.1 Measurement of blood pressure 
Blood pressure should be measured correctly with standard protocols and the common 
devices used are mercury column sphygmomanometer, electronic devices, aneroid 
sphygmomanometer and automated ambulatory BP devices. Even though 
sphygmomanometer is the gold standard, it is gradually being replaced by electronic 
blood pressure measurement (MOH, 2014). According to American Society of 
Hypertension and International Society of Hypertension (ASH/ISH), the electronic 
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device is preferred due to its reproducible results and it is not influenced by variations in 
technique or bias of the observers (Weber et al., 2014). 
In term of frequency in BP taking, different guideline came out with different 
frequency. Most clinical guidelines recommend averaging ≥ 2 BP measurements on 
each visit (Handler et al., 2012). Malaysia Clinical Practice Guidelines of Hypertension 
(4
th
 Edition) follows Canadian recommendations to take three readings in the same arm 
with later two readings averaged (MOH, 2014). However, JNC 7 and ASH/ISH 
recommended 2 readings with 1 to 2 minutes apart and use the average of these 
measurements (Chobanian et al., 2003; Weber et al., 2014). In this study, an electronic 
device OMRON (HEM – 7203) was used and 2 readings of BP were taken and the 
average values were taken as final BP. 
 
2.4.2 Physical activity assessment 
The goal standard for assessing total energy expenditure is the doubly labelled water 
method. Due to the expensiveness, high subject burden and time intensive, it is not often 
used for research studies. Many methods are there in assessing physical activity, the 
most commonly used are self-report questionnaires due to its cost effectiveness and ease 
of administration. Others are self-report activity diaries/log, direct observations or usage 
of devices like accelerometers, pedometers, armbands and heart-rate monitors (Sylvia et 
al., 2014). 
The commonly used self-report questionnaire is International Physical Activity 
Questionnaire (IPAQ), which is available in a short form or long form. Both forms are 
available in a number of languages and easily available through the IPAQ website. Both 
have been tested for reliability and validity in a number of countries (IPAQ, 2017). Chu 
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and her colleagues has demonstrated good validity and reliability of the Malay 
International Physical Activity Questionnaire (IPAQ-M) for the evaluation of physical 
activity (Chu and Moy, 2015). 
In this study, the IPAQ-M short form was used in assessing physical activity among the 
respondents due to cost effectiveness. Moreover it does not require longer time to 
complete the questionnaire. The IPAQ-M short form also was used in NHMS 2015 to 
assess our population physical activity (MOH, 2015). 
 
2.4.3 Assessing diet 
In measuring an individual’s dietary intake, several different approaches have been 
used. Generally, the methods of dietary assessment involved obtaining observations of a 
subject food intake by 24-H dietary recall or food record methods or attempts to get 
average of usual food intake by inquiring about the frequency of consumption. Food 
frequency questionnaire have been adopted in many studies to minimize day-to-day 
variation (Bazzano, 2005). 
In assessing healthy dietary practice in this study, only the portion of fruits and 
vegetables intake was assessed. The food frequency questionnaire in Malaysia NCD 
Surveillance -1 2005/2006 was used. It was adapted from WHO STEPwise approach to 
non-communicable disease risk factor surveillance (STEPS) 2001 and translated into 
Malay language to be used in our population (MOH, 2006). 
Consuming less than five total servings of fruit and vegetables per day is indicator for 
unhealthy diet-low fruit and vegetable intake. Our Malaysian Dietary Guidelines 2010 
also used the same indicator. The same food frequency questionnaire was used in our 
17 
 
NHMS 2015 in assessing dietary practice plus intake of plain water (MOH, 2015). Salt 
intake was not assess in this study in view of instrument used not included salt intake 
component. Furthermore, studies have shown in assessing high salt intake in diet, 
measurement of 24-hour urinary sodium excretion is the preferred method because of 
difficulties in estimating sodium intakes using dietary surveys (Brown et al., 2013). 
 
2.4.4  Assessing smoking characteristic through nicotine dependency 
Nicotine is the major addictive component in cigarette smoke. After smoking regularly, 
smokers will have both physical and psychological dependent. Due to this dependency, 
they have to smoke regularly to avoid the physical and psychological discomfort 
(Picciotto, 1998). Studies have shown there are associations between smoking and 
blood pressure due to the components in cigarette (Alshaarawy et al., 2013; Ambrose 
and Barua, 2004). 
 To objectively associate the components in cigarette smoke with prehypertension are 
not feasible in this study. The closest tools to associate cigarette component with 
prehypertension is The Fagerstrom Test for Nicotine Dependence questionnaire 
(FTND). It was derived from eight item Fagerstrom Tolerance Questionnaire 
(Fagerstrom and Schneider, 1989). This questionnaire is commonly used in clinical 
treatment and research. It  is a six items self-report questionnaire, easy to use, feasible, 
and gives immediate feedback with good sensitivity and specificity (Heatherton et al., 
1991).   
The Malay Version Of Fagerstrom Test For Nicotine Dependence (FTND-M) was 
validated and reliable to use in assessing nicotine dependence (HA et al., 2011). In this 
18 
 
study, FTND-M was used to assess nicotine dependence and the details will be 
explained in methodology segment. 
 
2.5  Rationale of the study 
Since JNC 7 introduced prehypertension in new classification of hypertension back in 
2003, it generated a widespread interest in this relatively new category. The new 
classification had merged the previous designated normal and high normal BP level 
where  the patient in this group of BP are now required to do follow up and lifestyle 
changes(Chobanian et al., 2003). Studies have shown that prehypertensive group of 
people at risk advancing towards hypertension and also at risk for cardiovascular 
disease later in life (Julius et al., 2006; Lewington S, 2002; Vasan et al., 2001). 
Since 2003, many have studied regarding the prevalence for prehypertension and its 
associated factors among general population and some had extracted the prevalence of 
prehypertension among smokers. Studies have shown cigarette smoking is associated 
with prehypertension and hypertension (Alshaarawy et al., 2013; Dochi et al., 2009) but 
some did not find any significant association (Grotto et al., 2006; Gupta et al., 2013b). 
However, looking at evidence both prehypertension and cigarette smoker are 
independent risk factors for cardiovascular disease, the risk for cardiovascular disease in 
cigarette smoker are higher. So far, there was no study looking specifically into 
associated factors among smoker with prehypertension yet.  
According to the latest NHMS 2015, among 5 million adult smokers in our country, 
most of them were in age group of 35 – 39 years old (MOH, 2015). Looking at the 
figures, these smokers are at risk for prehypertension and cardiovascular disease later. 
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Hence this study was done to evaluate what other associated risk factors for them to get 
prehypertension other than smoking since most of previous studies focusing on general 
population.  
The data and results obtained from this study will be used to improve our management 
among cigarette smoking patients. By detecting prehypertension among smokers and 
knowing their associated factors, early interventions and lifestyle modifications can be 
implemented to reduce their risk from developing cardiovascular events and motivated 
them to quit smoking and applied healthier lifestyle. 
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Figure 1: Conceptual framework  
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CHAPTER THREE: OBJECTIVES AND RESEARCH HYPOTHESIS 
 
3.1 Objectives 
 
3.1.1 General objectives 
To determine the prevalence of prehypertension and its associated factors among 
smokers attended Klinik Kesihatan Bandar Kota Bharu, Kelantan. 
 
3.1.2 Specific objectives 
1.To determine the prevalence of prehypertension among smokers attending Klinik 
Kesihatan Bandar Kota Bharu. 
2.To determine the associated factors for prehypertension among smokers attending 
Klinik Kesihatan Bandar Kota Bharu 
 
3.2 Research questions 
1. What is the prevalence of prehypertension among smokers attending Klinik 
Kesihatan Bandar Kota Bharu? 
2.What are the factors which contribute to prehypertension among smokers attending 
Klinik Kesihatan Bandar Kota Bharu? 
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3.3 Research hypothesis 
Specific sociodemography and modifiable  behavioural factors are associated with 
prehypertension. 
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CHAPTER FOUR: METHODOLOGY 
 
4.1 Study design, Operational Area and Timeline 
This study  is a cross sectional study and  conducted from January 2017 to April 2017 at 
Klinik Kesihatan Bandar Kota Bharu, Kota Bharu, Kelantan. This clinic  is located in 
the center of Kota Bharu district and 400m away from Hospital Raja Perempuan Zainab 
2. This clinic is a type 1 health clinic with daily attendance rate of 800 to 1000 patients 
per day.  The clinic opens every day from 7.30am to 9.30pm on working days and 
8.00am to 12.00pm during weekend and public holiday. The services covered are out 
patient, chronic disease and maternal and child health. 
 
4.2 Reference population 
The reference population in this study was all smokers in Kota Bharu, Kelantan. 
 
4.2.1 Source population 
The source population was all current smokers attending Klinik Kesihatan 
Bandar Kota Bharu from January 2017 to April 2017. 
 
4.2.2 Sampling Frame 
Klinik Kesihatan Bandar Kota Bharu attendees who currently smoke and 
fulfilled the inclusion and exclusion criteria as stated below: 
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4.2.2 (a) Inclusion Criteria 
1. Age 18 and above 
4.2.2 (b) Exclusion Criteria 
1. Having hypertension, diabetes mellitus, coronary heart disease,    
renal disease and stroke 
2. Suffered from mental illness 
3. Too ill during encounter 
4. Currently pregnant 
 
4.3 Sample size calculation 
The sample size for objective 1 was calculated by using the single proportion formula 
and  objective 2 was based on comparing two proportions formula using Power and 
Sample Size software version 3.0.10. 
According to the study done by Cheng KW et al in 2012,(Cheng et al., 2015) the 
prevalence of prehypertension among smokers was 24%. This figure was used for the 
calculation sample size in objective 1. 
 
Objective 1: To determine the prevalence of prehypertension in smokers attending 
Klinik Kesihatan Bandar Kota Bharu 
By using the single proportion formula, the confidence interval was set at 95% and 
taking precision as 0.05, the calculated sample size was: 
N = (Z/∆)² P(1-P) 
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n = minimum required sample size 
Z = value of standard normal distribution = 1.96 
∆ = precision value 0.05 
P = proportion of prehypertension among smokers was 0.24 
N = (1.96/0.05)² 0.24(1 – 0.24) 
   = 281 
When considering non response rate as 10%, the minimal sample size required was 310. 
 
Objective 2 : To determine the associated factors for prehypertension among 
smokers attending Klinik  Kesihatan Bandar Kota Bharu. 
The sample size was calculated by comparing two proportions using Power and Sample 
Size software version 3.0.10. The indicators required for the calculation was stated 
below. 
n = the required sample size 
Power = 0.8 
m = ratio between smokers with and without prehypertension 
P0 = the proportion of exposed associated factor without prehypertension in general 
population (there was no study on associated factors for prehypertension among 
cigarette smokers found) 
P1 = the proportion of exposed associated factor with prehypertension in smokers 
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The sample size calculation for associated factors for prehypertension among smokers 
in this study are shown in the following table. 
 
Table 2 : Sample size calculation based on literature review 
Variable P0 P1 m Minimal sample 
Gender (Xu et al., 2016) 0.26 0.41 1 308 
Educational level (Xu et al., 2016) 0.30 0.5 1 186 
Family history of hypertension 
(Meng et al., 2012) 
0.28 0.44 1 280 
Abdominal obesity (Xu et al., 2016) 0.17 0.35 1 184 
Heavy smoker(Cheng et al., 2015) 0.56 0.72 1 280 
 
From sample size calculation above, gender from objective 2 yields the highest sample 
size. Therefore the required minimum sample was 339 after considering 10% of non 
response rate. 
 
4.4  Sampling method 
Convenient sampling was used in this study. The researcher was aware about the 
limitation of this sampling method however this was applied in view of limited time 
frame and the respondents involved in this study include the registered and unregistered 
attendees to Klinik Kesihatan Bandar Kota Bharu. 
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4.5 Research tools 
The case report form consist of questionnaires for patient to answer and details of 
weight, height and blood pressure measurements by researcher. (Appendix 1) 
- Part A : The socio-demographic background of the respondents 
- Part B : Assessment on physical activity which was adapted from IPAQ-M 
short form 
- Part C : Assessment on dietary habit which was adapted from Malaysia NCD 
Surveillance-1 2005/2006 
- Part D : Assessment on smoking behaviour by using FTND-M 
- Part E : Physical measurements consist of BP, height, weight and waist 
circumference 
 
4.5.1  Part A : Socio-demographic data 
The first part of questionnaire consist data about gender, age, race, marital status, level 
of education, monthly income, family history of hypertension, past medical illness, 
duration of smoking and alcohol consumption. 
 
4.5.2 Part B : Physical activity assessment(IPAQ-M)(IPAQ, 2017) 
Physical activity of respondent was assessed by using the Malay validated International 
Physical Activity Questionnaire (IPAQ-M). It was designed primarily for population 
surveillance of physical activity among adults aged 18 – 69 years old. This instrument 
assesses three specific types of physical activity undertaken during leisure time, 
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domestic and gardening activities, work related and transport related activity and sitting 
for the past seven days. The three specific types of activity are walking, moderate 
intensity and vigorous intensity. There are total of seven questions in this instrument. 
Question 1 and 2 are on number of days and duration involved in vigorous physical 
activity. The activity considered vigorous if it required a lot of physical effort and make 
breathing much harder than usual. The examples of vigorous activities are heavy lifting, 
aerobic exercises or fast cycling. Question 3 and 4 are on number of days and duration 
involved in moderate physical activity. The activity considered moderate if it required 
moderate physical effort and breathing somewhat harder than usual. The examples of 
moderate physical activities are mopping floor, cycling bicycle at normal pace or 
playing badminton in double. Question 5 and 6 are on number of days and duration on 
walking. Question 7 is asking duration of time spent sitting in a day during normal 
working day. The duration of each three specific types of activity must be at least 10 
minutes, if the responses are less than 10 minutes, it was recode as zero. 
The respondents were considered not active physically if their activity pattern was less 
than ‘moderate’. The following criteria was classified as moderate: 
a) 3 or more days of vigorous-intensity activity of at least 20 minutes per day 
or 
b) 5 or more days of moderate-intensity activity and/or walking of at least 30 
minutes per day or 
c) 5 or more days of any combination of walking, moderate intensity or 
vigorous intensity activities achieving a minimum total physical activity of 
at least 600-MET-minutes/week 
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4.5.3 Part C : Dietary assessment (MOH, 2006) 
For the assessment of healthy diet, the Malay version of dietary component from 
Malaysia NCD Surveillance-1 2005/2006 (MyNCDS-1) was used. It was adopted from 
WHO STEPwise approach to chronic disease risk factor surveillance (STEPS).The 
questions assess the intake of servings of fruits and/or vegetables per day. There are 
four questions in the instrument. First question (Q1) is enquiring about number of days 
eating fruit in a typical week and Q2 is about number of servings of fruit intake in a day. 
Q3 is asking about number of days eating vegetables in a typical week and Q4 is 
clarifying the number of servings of vegetable intake in a day. The subjects were 
considered unhealthy diet if inadequate intake of fruits and vegetables if it less than five 
total servings per day. Intake of fruit and vegetables referred to all kinds of fruit and 
vegetables taken at meal times or as snacks. A medium size of fruit, a cup of raw green 
leafy vegetables and half cup of cooked vegetables are considered one serving. A 
template for common fruits and vegetables was included in questionnaire. 
 
4.5.4 Part D : Fagerstrom Test for Nicotine Dependence(FTND)-Malay validated 
(HA et al., 2011) 
There are six questions in FTND about smoking behaviour. The first question (Q1) is 
assessing the time of the first cigarette after waking up in the morning. Q2 is asking 
about the difficulty to refrain from smoking in the smoking forbidden places. Q3 is 
regarding the hardest cigarette to give up in a day. Q4 is about the amount of cigarettes 
smoked in a day. Q5 is the ability to smoke less during the first hours after waking up 
compared to the rest of the day and Q6 is asking about the ability to stop smoking in 
case of sickness. Based on the answers given, a score between 0 to 10 is obtained, with 
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higher scores indicating stronger dependence to nicotine. If the score is less than 4, 
subject is considered minimally dependent. If the score is between 4 to 6, subject is 
considered moderately dependent and if the score is 7 to 10, subject is considered highly 
dependent. 
 
4.5.5 Part E : Physical measurements (WHO, 2017) 
4.5.5 (a) Blood Pressure  
The measurements obtained by using a digital automatic blood pressure monitor, 
OMRON (HEM-7203) with appropriate cuffs size with the subjects. The subjects were 
in sitting position with the back supported, both feet on the floor and right arm 
supported on the table. During the measurements, the subject was advised not to talk. 
Two measurements were taken with 30 seconds to 1 minute apart on the same arm and 
the averaged value of that two readings were used in the analysis. 
 
4.5.5 (b) Weight and height  
Each participant weight and height were measured to get body mass index(BMI) by 
using a standardized protocol. To measure the height, the SECA stadiometer was used. 
Before measuring the height, subjects were asked to remove their foot wears. They were 
asked to stand with feet together and heels against the back board, eyes looking straight 
ahead and same level as the ears. Height will be measured to nearest 0.5cm. 
For weight measurement, a SECA scale was used. The scale was put on a firm and flat 
surface. Before measuring the weight, the subjects was asked to remove the shoes, bags 
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if any and empty out their pockets of mobiles, keys and wallets. They were asked to 
stand still, face forward and both arms on the side. Weight was measured with a lever 
balance to the nearest 100g. 
 
4.5.5 (c) Waist circumference  
It was measured using a measuring tape directly over the skin. The measurer sat by the 
side of the subject and fits the measuring tape snugly but not compressing soft tissues at 
the midpoint between the lower margin of the last palpable rib and the iliac crest. The 
The circumference was measured to the nearest 0.1cm. 
 
4.6 Ethical approval 
The study protocol was cleared by Human Reseach Ethics Committee USM (HREC) on 
2
nd
 August 2016. The approval for the study from Medical Research and Ethics 
Committee was applied and approved. (NMRR-16-2589-33491 (IIR). 
(Appendix 2 and 3) 
 
4.7 Data Collection Procedures 
The attendees to Klinik Kesihatan Bandar Kota Bharu were conveniently screened for 
smoking status. The cigarette smokers were invited to join the study if they fulfilled the 
inclusion and exclusion criteria. If they verbally consented to join the study, the subjects 
were brought to the consultation room and given patient information sheet and signed 
the consent forms.(Appendix 4). After that, the subjects were given questionnaire as 
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mentioned in research tools to fill up. After complete filling up the questionnaire, the 
blood pressures were measured and the second BP measurements were repeated after 30 
seconds to 1 minute rest. Then, the subjects were measured for height, weight and waist 
circumference. All the measurements procedure followed the standard stated in physical 
measurements above. Once finished, the subjects were informed about the findings and 
subjects with abnormal findings were referred for further managements and follow up. 
 
4.8 Data Entry and Analysis 
Total number of subjects recruited for this study was 339, however only 333 subjects 
completed the questionnaire. The data entry and analysis of 333 subjects were 
performed by using Statistical Package for the Social Sciences (SPSS) Statistic version 
22. Prior to analysis, data were checked, explored and cleaned. The distribution and 
frequencies were examined. All numerical variables were expressed as mean and 
standard deviation (SD) while categorical variables in frequency and percentage (%). 
The numerical variables include : 
1) Age of subjects 
2) Income of subjects 
3) Duration of smoking  
4) BMI 
5) Fagerstrom score  
The categorical variables include: 
1) Gender 
2) Race 
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3) Marital status 
4) Education level 
5) Family history of hypertension 
6) Alcohol consumption 
7) Physically active 
8) Healthy diet 
9) Central obesity 
The dependent variable in this study was prehypertension. 
Simple logistic regression was used to screen the variables for further step of analysis. It 
was then followed with multiple logistic regression analysis for variables with p-value 
of less than 0.25 and factors that have clinical significant. Then, the selected variables 
were analysed with backward and forward stepwise method to come out with 
preliminary model. The inclusion of variables in the preliminary model was based on 
the p value of less than 0.05. Then, the model were checked for multicollinearity and 
interaction. Finally, the fitness of the final model was checked using the Hosmer-
Lemeshow test, the classification table and the Reciever Operating Characteristic 
(ROC) curve for final model adequacy. 
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Figure 2: Flowchart of the study 
SOURCE POPULATION 
All current smokers attending Klinik Kesihatan Bandar Kota Bharu from    
 January 2017 to April 2017 
SAMPLING FRAME 
Klinik Kesihatan Bandar Kota Bharu attendees who currently smoke and fulfilled 
the inclusion and exclusion criteria 
SAMPLE 
Calculated sample size, N = 339, consented respondents, N = 333, 
response rate = 98.2% 
RESEARCH TOOLS 
1. Questionnaire consist of socio-demography, IPAQ-M, MyNCDS-1 Dietary, 
FTND-M 
2. Physical measurements of BP/Wt/Ht/WC 
 
Data entry and statistical analysis using SPSS version 22.0 
Report writing and data presentation 
 
SELECTION 
Inclusion and exclusion criteria 
SAMPLING METHOD 
Convenient sampling 
REFERRENCE POPULATION 
All cigarette smokers in Kota Bharu, Kelantan. 
 
35 
 
4.9 Operational Definitions 
1. Current smoker is defined as adult who have smoked 100 cigarettes in their 
lifetime and currently smoke cigarettes every day or some days (CDC, 
2009). 
2. Prehypertension is defined as systolic blood pressure from 120 to 139mmHg 
or diastolic blood pressure from 80 to 89mmHg (Chobanian et al., 2003). 
3. Race is classified into Malay and Others (Indian, Chinese and other races). 
4. Marital status is defined as current status of respondent. It was classified into 
unmarried, married, widow and divorcee. It was collapsed into married or 
single during analysis. The respondent who is never married, widow or 
divorcee was considered as single. 
5. Tertiary education level is defined as any formal education after secondary 
school. For analysis purpose, education level categorised into lower or high. 
Lower will comprised of primary and secondary level and high referred to 
tertiary level of education. 
6. Family history of hypertension is defined as any parent or sibling of 
respondent having hypertension. 
7. Body mass index (BMI) is defined as the weight in kilograms divided by the 
square of height in meters (kg/m²). It was categorised based on Malaysian 
Clinical Practice Guidelines of Obesity, 2004. Underweight (BMI < 18.5), 
Normal( BMI 18.5 – 22.9), Overweight (23 – 27.49), Obese (≥27.5) (MOH, 
2003). For statistical analysis with simple logistic regression and multiple 
logistic regression, the numerical data was used.  
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8. Central obesity is defined as waist circumference measurement 90cm or 
more for male and 80cm or more for female based on International Diabetes 
Institute/Western Pacific World Health Organization/International 
Association for the study of Obesity/International Obesity Task Force 2000 
(MOH, 2015)  
9. Physical inactivity is determined from validated Malay version of 
International Physical Activity Questionnaire (IPAQ) short form.  
The respondents were considered physically inactive if the pattern of activity 
is less than ‘moderate’. 
The pattern of activity to be classified as ‘moderate’  if 
a) 3 or more days of vigorous-intensity activity of at least 20 minutes per 
day or 
b) 5 or more days of moderate-intensity activity and/or walking of at least 
30 minutes per day or 
c) 5 or more days of any combination of walking,moderate-intensity or 
vigorous-intensity activities achieving a minimum total physical activity 
of at least 600METS-minutes/week (IPAQ, 2017). 
10. Unhealthy diet (low fruit and vegetable) is defined as not achieved dietary 
target total intake of  fruits and vegetable 5 servings of per day (MOH, 2006)  
11. Fagerstrom score was derived from FTND-M questionnaire, whereby the 
score was expressed from 0 to 10. The higher the number reflex higher 
nicotine dependency. The three severity for nicotine dependency are low if 
the score 0 -3, 4 to 6 signified moderate and 7 to 10 signified severe. For  
logistic regression and multiple logistic regression statistical analysis, the 
numerical data was used (HA et al., 2011) 
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CHAPTER 5 : RESULTS 
 
5.1  Overview of study respondents 
A total 333 of 339 cigarette smokers attending Klinik Kesihatan Bandar Kota completed 
the questionnaire with a response rate 98.2%. Other 6 respondents were unable to 
complete the questionnaire due to being called for consultation (n=4) and were in hurry 
to go back. 
 
5.2 Prevalence of prehytension and characteristics of respondents (n=333) 
The prevalence of prehypertension among smokers was 57.7% (n=192) and Table 3 
shows the characteristic of respondents. All the respondents were male and did not 
consume alcohol. Table 3 showed the characteristics of the respondents. The  mean 
(SD) age of respondents was 32.6 (10.3) with the minimum age was 18 years old and  
and maximum age was 62 years old. Majority of them were Malay (95.8), with more 
than half (57.1%) were married. The  mean (SD) years of smoking among respondents 
in prehypertensive group 15.6 (8.8) with mean (SD) Fagerstrom score was 2.7 (2.4) 
which is translated into low dependency to nicotine. Mean (SD) BMI of respondents 
was 23.7 (4.8) ,with half of the respondents were  overweight and obese with majority 
of them not eating enough fruits and vegetables. Among the overweight and obese 
respondents, 69% and 78% respectively, belong in the prehypertensive group. More 
than 60% of respondents in prehypertensive group had positive family history of 
hypertension in first degree relatives. 
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Table 3 : Characteristics of respondents 
Characteristics Total (n=333) 
 
n (%) 
Normotension 
(n =141) 
n (%) 
Prehypertension 
(n=192) 
n (%) 
Age (years)ᵃ 32.6 (10.3) 30.6 (9.4) 34.1 (10.7) 
Income (RM)ᵃ 1414.6 (1087.6) 1361.6 (1018.8) 1361.6 (1018.8) 
Smoking duration (years)ᵃ 14.4 (9.0) 12.9 (9.1) 15.6 (8.8) 
Fagerstrom score ᵃ 2.59 (2.3) 2.5 (2.0) 2.7 (2.4) 
BMI (kg/m²)ᵃ 23.7 (4.8) 21.9 (4.4) 25.0 (4.8) 
Race    
       Malay 319 (95.8) 136(42.6) 183(57.4) 
       Others 14 (4.2) 5 (35.7) 9 (64.3) 
Marital status    
       Single 142 (42.9) 70(49.0) 73(51.0) 
       Married 190 (57.1) 71(37.4 119(62.6) 
Level education    
       Low 232 (69.7) 95(40.9) 137(59.1) 
       High 101 (30.3) 46(45.5) 55 (54.5) 
Family history hypertension    
      No 172 (51.7) 84(48.8) 88(51.2) 
      Yes 161 (48.3) 57(35.4) 104(64.6) 
Physical inactive    
      No 120 (36.0) 95(44.6) 118(55.4) 
      Yes 213 (64.0) 46(38.3) 74(61.7) 
Unhealthy diet    
      No 34 (10.2) 19(55.9) 15(44.1) 
      Yes 299 (89.8) 122(40.8) 177(59.2) 
Central obesity    
     No 231 (69.4) 121(52.4) 110(47.6) 
     Yes 102 (30.6) 20 (19.6) 20 (19.6) 
ᵃ The variables are expressed as mean (SD) 
 
 
5.3 Associated factors for prehypertension  
There were 14 variables intended for exploration of associated factor. However, the 
variable sex and alcohol was not suitable to be included due to the inavailability of the 
sample. Twelve variables were proceded with simple logistic regression. Table 4 shows 
the findings of associated factors for prehypertension using simple logistic regression.  
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All clinically and statistically significant variables were included for multiple logistic 
regression analysis.  
Based on multiple logistic regression, five variables, namely, age (p=0.020), family 
history of hypertension (p=0.034), unhealthy diet (p=0.001), BMI (p=0.006) and central 
obesity (p=0.014) were significantly associated with prehypertension as shown in Table 
5. 
Table 4: Associated factors for prehypertension among cigarette smokers by Simple 
Logistic Regression 
 
Variables Regression 
coefficient 
(b) 
Crude odds ratio 
(95% CI) 
Wald 
statistic 
p-value 
Age (years) 0.03 1.04 (1.01, 1.06) 9.4 0.002 
Income (RM) 0.00 1.00 (1.00, 1.00) 0.6 0.446 
Smoking duration (years) 0.03 1.04 (1.01, 1.06) 6.9 0.008 
Fagerstrom score 0.05 1.05 (0.95, 1.15) 0.94 0.332 
BMI 0.16 1.17 (1.11, 1.24) 30.8 <0.001 
Race     
    Malay  1   
    Others 0.29 1.34 (0.43, 4.08) 0.26 0.609 
Marital status          
    Single  1   
    Married      0.47 1.61 (1.03,2.49) 4.46 0.035 
Family history hypertension     
     No  1   
     Yes 0.55 1.74 (1.12, 2.70) 6.10 0.013 
Education level     
     Low  1   
     High -0.18 0.83 (0.52, 1.32) 0.61 0.435 
Physical inactivity          
     No  1   
     Yes 0.26 1.29 (0.82, 2.04) 1.23 0.267 
Unhealthy diet     
    No  1   
    Yes 0.61 1.84 (0.89, 3.76) 2.78 0.095 
 Central obesity     
    No  1   
    Yes 1.51 4.51(2.59,7.83) 28.5 <0.001 
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Model assessment shows that there was no multicollinearity problem and  significant 
interaction terms. Hosmer-Lemeshow test with p-value (0.632), the overall correctly 
classified percentage from classification table (69.4%) and the area under the ROC 
curve was 0.749 (95% CI 0.70,0.80)  showed that the model was fit. Therefore final 
model in Table 7 was fit for interpretation. 
 
Table 5 : Associated factors for prehypertension among cigarette smokers by Multiple 
Logistic Regression 
Characteristic Regression 
coefficient 
(b) 
Adjusted odds 
ratioᵃ (95% CI) 
Wald 
statistic 
p-value 
Age (years) 0.03 1.03 (1.00, 1.05) 5.42 0.020 
BMI (kg/m²) 0.11 1.11 (1.03,1.20) 7.63 0.006 
Family history hypertension     
        No 0 1   
        Yes 0.52 1.68 (1.04, 2.71) 4.47 0.034 
Unhealthy diet     
        No 0 1   
        Yes 1.50 4.48 (1.88, 10.63) 11.57 0.001 
Central obesity     
         No 0 1   
         Yes 0.99 2.68 (1.22,5.89) 6.05 0.014 
ᵃ Forward LR Multiple Logistic Regression model was used for final model. 
Multicollinearity and interaction terms were checked and not found. 
Hosmer-Lemeshow test, (p=0.632), classification table (overall correctly classified 
percentage=69.4%), and area under the ROC curve (74.9%) were applied to check the 
model fitness. 
 
 
5.6 Interpretation of significant results 
 
1.  The adjusted OR for age was 1.03 (95% CI 1.00, 1.05,p=0.020). For every one 
year increase in age, there will be 1.03 times at odds of prehypertension compare to 
normotension 
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2. The adjusted OR for BMI was 1.1 times (95% CI 1.03,1.20,p=0.006). For every 
one kg/m² increase in BMI, there will be 1.11 times at odds of prehypertension compare 
to normotension 
 
3. The adjusted OR for prehypertension versus normotension for  positive family 
history of hypertension in first degree relatives was 1.7 times (95% CI 
1.04,2.71,p=0.034) .There was  1.7 times at the odds family history of hypertension 
compared to no family history of hypertension  
 
4. The adjusted OR for prehypertension versus normotension for  low intake of 
fruits and vegetables was 4.5 times (95% CI 1.88,10.63,p=0.001). There was  1.7 times 
at the odds low intake of fruits and vegetables compared to enough intake of fruits and 
vegetables 
 
5. The adjusted OR for prehypertension versus normotension for  central obesity 
was 2.7 times (95% CI 1.22,5.89,p=0.014). There was 2.68 times at the  odds central 
obesity compared to without central obesity after adjusting for other variables among 
smokers attending  Klinik Kesihatan Bandar Kota Bharu. 
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CHAPTER 6 : DISCUSSION 
 
Non communicable disease and specifically cardiovascular disease is currently the top 
silent killer in human population worldwide and locally. Our local and WHO statistic  
have shown that the trend is becoming worrying since it shows uprising every year. 
Prehypertension is currently recognised as potential and  proven entity in contributing to 
the development of cardiovascular disease (Chobanian et al., 2003). On the other hand, 
the effect of smoking on cardiovascular disease already established for a much longer 
time (Ambrose and Barua, 2004). 
 
Hence, cigarette smokers with prehypertension are exposed to bigger risk for 
cardiovascular disease. In knowing what are associated factors for smokers to get 
prehypertension, a timely intervention can be implemented and prevent them from 
getting prehypertension and subsequently hypertension.  
 
6.1 Socio-demographic background of study respondents 
 
From a few series of NHMS, the national prevalence of current cigarette smokers in 
adult age 18 and above remained at about 25% since 2011 and 2015. Number of 
cigarette smokers among adolescents are getting higher whereby every 1 in 10 
Malaysians in the age group 13 -17 years old, were smokers (Wee et al., 2016).  In 
2015, the estimated current smokers among Kelantanese was about 280 000 people or 
24.6% out of total population in Kelantan (MOH, 2015) . So, this study only covered a 
fraction of current smokers in Kelantan. 
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As shown in the results, all of respondents were male and NHMS 2015 showed number 
of male smokers were 30 times higher than female smokers (MOH, 2015) and a  study 
had shown being male significantly associated with tobacco used (Wee et al., 2016). 
The age range of current smokers in this study were from 18 years old to 62 years old 
with mean (SD) age in prehypertension group slightly older, 34.1 (10.7), compared to 
mean (SD) age in normotensive group, 30.6 (9.4), 64% of prehypertension group were 
married and about 70% of them completed secondary school with mean (SD) income 
RM1453.6 (1136.5) monthly, showing most of our respondents were above poverty 
level (JPM, 2017).  
 
 Generally, the background findings of our respondents not differ much from national 
findings of currents cigarette smokers in Malaysia (MOH, 2015). Mean years of 
smoking duration among respondents in prehypertensive group was 15.6 (±SD), slightly 
longer duration than normotensive group. However, smoking duration in our 
respondents slightly shorter compared to a study done previously in Kelantan shown 
much longer duration, 23.9 years (Wee et al., 2016).  
 
Among the respondents, 64% of them are physically active, similar with finding among 
our national population about 66.5%. However, almost 90% of  our overall respondents 
not practising healthy dietary habit as their intake of fruits and vegetables were less than 
5 servings per day similar with  national statistic among general  population (MOH, 
2015). Respondents in  prehypertensive group slightly higher proportion at 59.2% 
compared to normotensive group at 40.8% in inadequate intake of fruits and vegetables. 
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Physical characteristic of our respondents were slightly in overweight category, with 
mean (SD)  BMI was 23.7 (4.8)  and 30% of  them had central obesity. The mean (SD) 
SBP in our respondents was 120.9 (10.3) and mean (SD) DBP was 74.1 (7.5). A study 
in Japan among 3432 cigarette smokers shown almost similar findings, mean (SD) BMI 
22.8 (2.8), mean (SD) SBP was 120.9 (10.6) and mean (SD) was DBP 73.8 (8.0)(Dochi 
et al., 2009). Both findings of SBP among cigarette smokers were in prehypertensive 
range. 
 
6.2 Prevalence of prehypertension among current smokers attending Klinik 
Kesihatan Bandar Kota Bahru. 
 
In this study, we found that 192 out of 333 (55.7%) current smokers attending Klinik 
Bandar Kota Bharu had their blood pressure within prehypertensive range with mean 
(SD) SBP was 127.4 mmHg (7.8) and mean (SD) DBP was 77.9 mmHg (6.6). 
In Malaysia, there was not much data for comparison on prevalence of prehypertension. 
The latest data was from a study among under graduate students in public university 
done in 2013 shown prevalence prehypertension among cigarette smoking students was 
45%.The figure slightly lower compared to our findings.  
 
However that study was done among younger population with their age range from 18 
to 26 years old and the number of respondents whom smoked were 40 students only 
from 495 students involved in the study (Salmiah et al., 2014). This could explained 
why the prevalence higher because our respondents were in older age group, mean (SD) 
age was 32.8 (10.7). 
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 A study in Singapore showed prevalence of prehypertension among Malay smoker 
were 30.4% (Chiang et al., 2013) and a study done in rural Indonesia among young 
adults age 18 – 25 years old attended a primary health care, showed 15.8% out of total 
prehypertensive patients were smokers (82) Both of these results showed lower 
prevalence could be due to different in target population studied. However, a study 
among male Japanese steel worker showed higher prevalence. Among 3972 
prehypertensive workers, 51.1%  of them were smokers (14).  
 
Table below summarizes other prevalence of prehypertension in other countries. Most 
of the studies done on general population, not  specifically on smokers. The different in 
target group and study population, race, age and lifestyle might be the reason for 
variation in prevalence. 
 
Table 6 : Comparison prevalence prehypertension among smokers between this study 
and previous studies 
Author (year) Place of study Population Prevalence 
Balami et al., 
(2013) 
Public universities in 
Malaysia 
Undergraduate students 
 
45% 
Chiang PP et al., 
(2013) 
South Western of 
Singapore 
Malay Ethnic 
 
30.4% 
Widjaja et al., 
(2013) 
Sukabumi District, 
West Java 
Younger adults age 18 -25 
years old 
15.8% 
Gupta et al., 
(2010) 
Whole Cambodia General population 32.5% 
Xu et al., 
(2016) 
Whole China General population 39.9% 
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Ishikawa et al., 
(2008) 
12 rural districts General population 51.1% 
Singh et al., 
(2011) 
5 Indian Cities General Population 30.5% 
 
 
6.3 Associated factors for prehypertension among smokers 
 
Besides knowing the prevalence of prehypertension, we aim to know the associated 
factors for them to develop prehypertension. From multiple logistic regression analysis, 
there were five factors noted to have significant association with prehypertension 
among smokers. There were age, BMI, family history of hypertension, inadequate 
intake of fruits and vegetables and presence of central obesity. Physical inactivity, 
smoking characteristics and certain socio-demography aspects show no significant 
association with prehypertension. 
 
6.3.1 Age 
 
 From the study noted that with increasing age, cigarette smokers exposed to 
development of prehypertension (OR=1, 95% CI 1.00,1.05,p=0.020). The finding of 
significant association between age and prehypertension were demonstrated in other 
studies(Meng et al., 2012; SIngh et al., 2011; Xu et al., 2016). Study by Vinay  Gupta 
among Cambodian adult in age group 25 – 64 years old revealed age the most 
significant factor for developing prehypertension and the magnitude of the odd ratio 
being consistently greater in correlating with the development of hypertension(Gupta et 
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al., 2013b). Esam et al shown both mean SBP and DBP increased steadily with the 
increase in age (Esam and Husain). 
 
Midha T et al study also showed significant association between blood pressure and age 
with mean SBP increased steadily with age but for DBP increment up to 60 years 
resulted in wide pulse pressure pressure (Midha et al., 2009).The changes of blood 
pressure with age might be due to changes in vascular system. Increasing age is 
associated with loss of arterial elasticity which reduced arterial compliance (B. Jani, 
2006). Cigarette smokers should be advised to come for regular scheduled medical 
checked up. 
 
6.3.2 Body mass index 
 
This study had shown with increasing BMI, higher the odds to develop prehypertension 
( OR=1.1, CI 95% 1.03,1.20,p=0.006). The significant finding of  BMI association with 
prehypertension consistent with findings from other studies (Gupta et al., 2013b; Xu et 
al., 2016; Yang et al., 2010).  A study among our public university undergraduates  had 
demonstrated that overweight and obese were almost 6 times and 11 times respectively, 
likely to have prehypertension compared to underweight (Salmiah et al., 2014).  
 
A study in Singapore among three ethnics demonstrated BMI were significantly 
associated with prehypertension with Chinese (OR= 1.42,CI 95% 1.1,1.8), Malay 
(OR=1.53 CI 95% 1.05,2.24) and Indians (OR=1.49, CI 95% 1.13,1.98) (Chiang et al., 
2013). Grotto et al suggested obesity was a major determinant of prehypertension after 
controlling other risk (Grotto et al., 2006). A meta-analysis revealed higher body mass 
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associated with prehypertension and with some weight reduction can give some effect 
of lowering blood pressure(Guo et al., 2011) 
 
A study by Kawamoto and colleague examined the association between body weight 
status and prehypertension. It revealed increasing BMI categories, higher odds for a 
person to get prehypertension, from 1.9  in BMI category of 21 – 24 kgm2 to  3.79 in 
the ≥ 25 kg/m²(Kawamoto et al., 2008). Another study also revealed a close association  
between continuous variables of BMI with blood pressure and with certain weight 
reduction can reduced the blood pressure (Jones, 1996). Among documented factors 
linking obesity to increased blood pressure include dietary factor, metabolic, sodium 
retention and neuroendocrine imbalances (DeMarco, 2014). Cigarette smokers beyond 
optimal BMI should be advised for weight reduction. 
 
 
6.3.3 Family history of hypertension 
 
 History of hypertension among first degree relatives was another significant finding 
noted from this study. Those with positive family history had 1.7 higher odds for 
prehypertension compared to none.(CI 95% 1.04,2.71,p=0.034).This finding was 
supported from other study among 4200 employees in China showed 35% among 
prehypertensive had positive family history of hypertension. The results of analysis 
showed individuals with positive family history had greater risk of prehypertension and 
hypertension than those without after adjusting the confounders (Shen et al., 2017).  
 
Another study also shown those with positive family history of hypertension had two 
times higher in getting prehypertension(Salmiah et al., 2014).. A study in Indonesia 
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differentiated family history into maternal or paternal side and showed significant 
finding in positive family history from maternal side compared to paternal (Widjaja et 
al., 2013). Literature from familial and twin studies has shown 30% -50 % of blood 
pressure reading due to genetic heritability and environmental factor contribute about 
50% (Butler, 2010)  
Another study demonstrated having both parents diagnosed with hypertension before 
the age 55 years old , gave 6.2 times higher for the development of hypertension (Wang 
et al., 2008). The importance of knowing family medical history should be emphasized 
on our patient and whom with positive family history should do regular health 
screening. 
 
6.3.4 Unhealthy diet – inadequate intake of fruits and vegetables 
 
Those with inadequate intake of fruits and vegetables less than five times per day  had 
4.5 times higher odds for prehypertension (CI 95%1.88,10.63, p=0.001). A study by Li 
et al showed significant association between elevated diet score and prehypertension. 
However in this study, they assessed both meat and vegetable consumption in a week. 
Higher diet score showed higher meat and lower vegetable intake (Li et al., 2014). The 
well-known DASH diet have shown to reduce blood pressure ((Appel, 2009; Karanja et 
al., 2007).  
 
However the limitation in this study was dietary salt intake was not assess, however a 
study in India also showed positive association between prehypertension with low 
intake of vegetables. The same method for dietary assessment was used just based on 
vegetable servings without salt intake assessment (Gupta et al., 2013a). Fruits and 
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vegetables content  dietary nutrient like antioxidants, potassium and folic acid in fruits 
and vegetables give protective effect toward blood pressure and cardiovascular disease 
(Bazzano et al., 2002) From meta-analysis on food and vegetable consumption with 
hypertension also showed food and vegetable have inversed relationship with risk for 
high blood pressure (Li et al., 2016). The patient should be advised on adequate intake 
of fruits and vegetables with reduced used of salt in daily meal plan. 
 
6.3.5 Central obesity 
 
The findings from this study showed smokers with central obesity were 2.7 times the  
odds to have prehypertension.(95% CI 1.22,5.89,p=0.014). A study in Cambodia by 
Gupta and colleague showed central obesity was significantly associated with 
prehypertension with OR 1.97 (CI 95% 1.54,2.51)(Gupta et al., 2013b). A study in 33 
communities in China showed respondents with abdominal obesity had higher SBP 
(137± 22.7) and DBP (86.4±12.1) compared to those without abdominal obesity (Deng 
et al., 2013). 
 
A study on almost 7000 subjects from 5 cities in India, showed central obesity was 
strongly associated  with prehypertension in both male (OR=1.22 CI 95% 1.14,1.23) 
and female (OR=1.19 CI 95% 1.14,1.23)(SIngh et al., 2011). Central obesity was linked 
to high blood pressure by activation of chronic inflammation from increasing visceral 
adipose tissue accumulation whereby the same process also commonly associated with 
hypertension(Chiang et al., 2013).  The other important implication of central obesity  is 
in relation to metabolic syndrome. Study have shown that smoking increased risk for  
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prediabetes development (Aeschbachera et al., 2014) Hence, smokers with abdominal 
obesity should be screened for metabolic syndrome. 
 
6.3.6 Physical inactivity 
 
Finding from this study showed no significant association between physical inactivity 
and prehypertension (OD=1.29,CI 95% 0.82,2.04,p=0.267). The study among 
undergraduate students with the same tool used  in our study for physical activity 
assessment showed  no significant association between physical activity with 
prehypertension even with moderate physical activity (OR=1.2, CI 95%) 0.77,2.78, 
p=0.467) (Salmiah et al., 2014). 
 
The study in Indonesia also used same assessment tool as our study, showed an 
association between physical activity but not significant (OR=2.6,CI 95% 
0.98,6.93,p=0.052) (Widjaja et al., 2013). However , a study in India with different 
assessment tool showed sedentary life style significantly associated with hypertension 
for both sex, female (OR=1.57,CI95% 1.32,1.85) and male (OR=1.59, CI95%1.33,1.88) 
(SIngh et al., 2011).  
 
The different in results could be due to different instruments used in assessment of 
physical activity since recent data from prospective study still showed exercise 
interventions have effect on blood pressure among normotensives and prehypertensives 
(Diaz and Shimbo, 2013). On the other hand, IPAQ-SF still recommended to use in 
clinical and research for outcome measure (Shamsuddin et al., 2015; Silsbury et al., 
2015). Possibility of over estimation by respondents in assessing self-physical activity 
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gave the different results. Therefore, regular physical activity as recommended by 
guideline should be advised to patient. 
 
 
6.3.7 Smoking characteristic 
 
In this study, smoking characteristic was assessed by the duration of smoking and 
nicotine dependency through FTND-M questionnaire. For smoking duration, mean (SD) 
years of smoking among prehypertensive group was 15.6 (8.8). During earlier analysis 
using simple logistic regression showed significant association, crude OR 1.04(SD 
1.01,1.06, p=0.008),  but after analysis using multiple logistic regression, there was no 
significant association seen.   
 
Mean (SD) Fagerstrom score among our prehypertensive group was 2.7(2.4), which was 
not much different from non-hypertensive group, 2.5(2.0) indicated low dependency to 
nicotine. The variable was  not significant even with simple logistic regression 
(OR=1.34 ,CI 95% 0.43, 4.08, p=0.609). 
 
 Based on a population based study among 910  cigarette smokers in Vietnam looking 
for association between smoking and hypertension ,both lifetime smoking duration and 
intensity (pack-years) were associated with hypertension after adjusted other factors 
(BMI and alcohol). However the duration of smoking > 30years and >20 pack-years 
showed the significant association for hypertension (Thuy et al., 2010). 
 
Compare to this study, the mean duration of smoking among our respondent was 15.6 
and mean fagerstrom 2.7 (low dependency), this could explained  the finding  of no 
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significant association found between smoking characteristic with hypertension. The 
same study also demonstrated current smokers not significantly associated with 
hypertension, but looking at the mean SBP and DBP among current smokers were in 
prehypertensive range (Thuy et al., 2010) Another study in Kunming, China among 
male factory workers showed heavy smokers associated with prehypertension and more 
dependent on nicotine. Heavy smokers here classified as smoked >20 cigarettes day 
(Cheng et al., 2015). From these two studies, smokers at risk for prehypertensive if the 
cigarettes smoked > 20  and life time duration >30 years. 
 
6.3.8 Socio-demographic factor 
 
The socio-demographic factors that were look in for association were race, level of 
education, monthly income and marital status. From simple logistic regression only 
being married showed association with prehypertension (crude OR=1.61,CI 95% 1.03, 
2.49), however the association was not significant after multiple logistic regression 
analysis. Meanwhile other factors did not show association with prehypertension. 
Similar findings were noted in these study (Gupta et al., 2013b; Yang et al., 2010).  
 
A study in  Singapore showed lower education positively associated with 
prehypertension (Chiang et al., 2013), this was  supported by finding from Xu et al 
showed higher educational level was protective factor for prehypertension (Xu et al., 
2016).The different categorization for educational level here might explained the 
opposite findings. The study in Singapore classified into primary and below as one 
group and secondary and high as second group.  Meanwhile, study in China classified 
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into three categories, illiterate and primary as one group, high school as one group and 
university in one group. 
 
 
6.4 Limitation of the study 
 
Through out the process in carrying out this study, all efforts had been made to ensure 
valid data and reliable results were obtained in this study. Outlined below were some 
limitations encountered in the study. 
 
The label of prehypertension in this study was based on single visit only and Malaysia 
Clinical Practice Guidelines on Management of Hypertension (4
th
 Edition) had 
recommended two different visits were required in diagnosing. The single visit of blood 
pressure might overdiagnosed prehypertension here despite averaged of two readings 
were taken as indicator BP. 
 
The represented data  were majority from Malay ethnic, thus it not reflect other ethnics 
in Kota Bharu and this study did not explore other associated factors for 
prehypertension such as dyslipidemia,  dysglycemia and psychological factors that 
might interact  with studied associated factor. 
 
The sampling method used in this study was convenient sampling method  that could 
affect the finding of this study and the tool used for assessment of unhealthy diet only 
assessed fruits and vegetable intake but not included salt intake assessment as salt are 
highly associated with blood pressure. 
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CHAPTER 7 : CONCLUSION 
 
The percentage of prehypertension among smokers attending Klinik Kesihatan Bandar 
Kota Bharu is 192 (57.7%). This study identified five factors that had significant 
association with prehypertension among smokers which were age, BMI, positive family 
history of hypertension in first degree relatives, unhealthy diet which is inadequate 
intake of fruits and vegetables less than five servings per day and central obesity 
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CHAPTER 8 : RECOMMENDATION 
 
Some of the recommendations are more studies are needed to assess other important 
socio-demographic, behaviour and biological factors that may influence prehypertensive 
development in cigarette smokers due to lack of study at the moment. Other than that, 
proper tools for assessment of behaviour associated factors such as objective methods 
for assessment of physical activity and whole dietary assessment included salt intake 
component to signify unhealthy diet. Finally, a proper sampling method should be used 
to get more reliable findings. 
 
 
 
 
. 
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APPENDIX 1 :  Case report form 
 
KAJIAN MENGENAI PREVALENS PRAHIPERTENSI  DAN FAKTOR BERKAITAN  DI KALANGAN 
PEROKOK YANG HADIR KE KLINIK KESIHATAN BANDAR KOTA BHARU 
 
Bahagian A: Latarbelakang diri 
1. Jantina:    Lelaki   Perempuan 
2. Umur:   _______ tahun 
3. Bangsa:  Melayu   Cina   India   Lain-lain:    Nyatakan________ 
4. Status perkahwinan: 
Bujang   Berkahwin   Berpisah / Kematian pasangan 
5. Tahap pendidikan:  
Sekolah rendah    Sekolah Menengah  
Diploma/ Ijazah    
6. Pekerjaan: 
7. Pendapatan sebulan   :  ______________(RM) sebulan 
8. Sila tandakan (√ ) pada penyakit yang terdapat dalam adik-beradik atau ibubapa anda 
Kencing manis 
Tekanan darah tinggi (Hipertensi) 
Sakit jantung koronari/saluran jantung tersumbat 
Angin ahmar/strok 
 Kematian mengejut (Sudden death) semasa umur kurang daripada 55 tahun untuk 
lelaki dan umur kurang daripada 65 tahun ) 
9.Adakah anda mempunyai penyakit kronik selain dari yang dinyatakan di borang persetujuan 
kajian 
---------------------------------------- 
10.Berapa lama sudah anda merokok  
------------------------------------------------ 
11. Pengambilan alcohol/ minuman keras/ arak/tapai; 
-  Adakah anda sekarang mengambil sebarang jenis arak seperti bir, wain, tuak yang ditapai 
atau apa-apa minuman keras? 
 
 Tidak ( <1 unit seminggu untuk wanita/ <2 unit seminggu untuk lelaki ) 
 
 
 Sederhana ( <1 unit sehari untuk wanita/ <2 unit sehari untuk lelaki 
 Teruk (melebihi 3 unit sehari atau 7 unit seminggu bagi wanita) 
/(melebihi 4 unit sehari atau 14 unit seminggu bagi lelaki ) 
Satu unit arak: Beer (12 aun=355ml); wine (5 aun=148ml);alcohol lain(1.5 
aun=44ml) 
 
B.  Aktiviti Fizikal (IPAQ –M) 
Sila fikirkan tentang aktiviti anda di tempat kerja, di rumah dan kawasan halaman, untuk 
bergerak dari satu tempat ke tempat yang lain, dan pada waktu lapang untuk rekreasi, 
senaman atau bersukan. 
 
1. Dalam tempoh 7 hari yang lepas ini, berapa harikah anda telah melakukan aktiviti fizikal 
berat, sekurangkurangnya 10 minit pada sesuatu masa?  
Aktiviti fizikal berat adalah aktiviti  menggunakan daya tenaga fizikal yang kuat dan membuat 
anda bernafas jauh lebih kuat daripada biasa, contohnya mengangkat barang berat, 
mencangkul, senaman aerobik atau berbasikal laju. 
_______ hari seminggu 
Tiada aktiviti fizikal berat Lompat ke soalan 3 
 
2. Berapakah masa yang anda biasa gunakan untuk melakukan aktiviti fizikal berat pada salah 
satu daripada hari berkenaan? 
_______jam _____minit sehari   Tidak tahu / Tidak pasti 
 
3. Dalam tempoh 7 hari yang lepas ini, berapa harikah anda telah melakukan aktiviti fizikal 
sederhana, sekurang-kurangnya 10 minit pada sesuatu masa? 
Aktiviti fizikal sederhana adalah aktiviti yang menggunakan daya tenaga fizikal yang sederhana 
dan membuatkan anda bernafas agak lebih kuat daripada biasa, contohnya mengangkat 
muatan ringan, mengelap lantai, berbasikal pada kelajuan biasa, atau bermain badminton 
beregu? Ini tidak termasuk berjalan kaki. 
 
_______hari seminggu 
Tiada aktiviti fizikal sederhana Lompat ke soalan 5 
 
 
 
4. Berapakah masa yang anda biasa gunakan untuk melakukan aktiviti fizikal sederhana pada 
salah satu daripada hari berkenaan? 
_______jam ______minit sehari   Tidak tahu / Tidak pasti 
5. Dalam tempoh 7 hari yang lepas ini, berapa harikah anda telah berjalan kaki selama 
sekurang-kurangnya 10 minit pada sesuatu masa? 
_______hari seminggu 
          Tiada berjalan kaki Lompat ke soalan 7 
 
6. Berapakah masa yang anda biasa gunakan untuk berjalan kaki pada salah satu 
daripada hari berkenaan? 
_______jam _______minit sehari   Tidak tahu / Tidak pasti 
 
7. Dalam tempoh 7 hari yang lepas ini, berapakah masa yang anda telah gunakan 
untuk duduk pada sesuatu hari bekerja? 
_______jam _______minit sehari    Tidak tahu / Tidak pasti 
 
 
C. Pemakanan  (Bagi menentukan saiz bagi satu hidangan, sila lihat lampiran yang disertakan) 
1. Dalam masa seminggu biasa anda, berapa harikah anda makan buah-buahan? ______ hari 
2. Dalam satu hari yang biasa, berapa hidangan buah-buahan yang anda makan?______sajian 
3. Dalam masa seminggu biasa anda, berapa harikah anda makan sayur-sayuran? ______ hari 
4. Dalam satu hari yang biasa, berapa hidangan sayuran yang anda makan?______sajian 
 
D. Borang Skor Fagerstrom 
1.Berapa cepatkah anda menghisap rokok yang pertama selepas bangun dari tidur? 
Dalam masa 5 minit (3) 
6 hingga 30 minit (2) 
31 hingga 60 minit (1) 
Selepas 60 minit (0) 
2. Adakah anda berasa sukar untuk tidak merokok di tempat larangan merokok? Contohnya di 
sekolah, kompleks membeli belah, perhentian bas 
Ya (1) 
Tidak (0) 
 
 
 
 
3. Menghisap rokok yang manakah yang paling sukar untuk anda tinggalkan 
Yang pertama di sebelah pagi (1) 
Yang lain (0) 
 
4. Berapa batang rokok yang anda hisap dalam sehari? 
10 atau kurang (0) 
11 hingga 20 (1) 
21 hinggaa 30 (2) 
31 atau lebih (3) 
 
5.Adakah anda lebih kerap merokok dalam jam pertama selepas bangun tidur berbanding 
masa lain sepanjang hari 
Ya (1) 
Tidak (0) 
 
6. Adakah anda masih merokok walaupun anda sakit teruk dan terpaksa berbaring di atas katil 
untuk kebanyakan masa 
Ya (1) 
Tidak (0) 
Jumlah markah : 
 
BAHAGIAN E:   PEMERIKSAAN 
 
1. Tinggi    :  
2. Berat     : 
3.BMI        : 
4. WC        : 
5. BP          :    1. 
           2. 
          Purata : 
  
 
 
 
 
 
 
 
LAMPIRAN PEMAKANAN 
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APPENDIX 4: Patient's consent fonn 
iiiUb-MI 
UNIVERSITI SAINS MALAYSIA 
Research Title: 
Researcher's Name: 
INTRODUCTION 
ATTACHMENT B 
RESEARCH INFORMATION 
Prevalence of prehypertension among smokers attending 
Klinik Kesihatan Bandar Kota Bharu and its associated 
factor 
Dr Nor Khairi Binti Deris (MMC: 41765) 
Dr Nani Draman (MMC: 35488) 
Dr Azlina Ishak (MMC: 37546) 
You are invited to take part voluntarily in a research study on prevalence of 
prehypertension among smokers attending Klinik Kesihatan Bandar Kota Bharu and its 
associated factor. Prehypertension is defined as systolic blood pressure (SBP) of 120 to 
139 mmHg or a diastolic blood pressure (DBP) of 80 - 89 mmHg in adults 18 years and 
older. People with prehypertension are at increased risk for progression to hypertension. 
Both prehypertension and hypertension are risk factors for cardiovascular disease, 
stroke and heart attack. Before agreeing to participate in this study, it is important that 
you read and understand this research information form. Please take time to read and 
understand the information carefully. If you decide to participate, you will receive a 
copy of this form to keep for your records. Your participation in this study will take 
about 15 minutes. Up to 339 respondents will be participating in this study. 
PURPOSE OF THE STUDY 
This study is conducted to determine the proportion of prehypertension among smokers 
whom attended Klinik Kesihatan BandarKota Bharu and to identify certain associated 
factors affecting the blood pressure. 
QUALIFICATION TO PARTICIPATE 
The doctor in charge of this study or any research assistant has discussed with you the 
requirements for participation in this study. It is important that you are completely 
truthful with the doctor and staff about you health history. You should not participate in 
this study if you do not meet all the qualifications. 
The requirements to be in this study are: 
• Age more than 18 years 
You cannot participate in this study if: 
• You are known of or currently treated for chronic diseases such as diabetes 
mellitus, hypertension, heart disease, renal impairment and stroke 
 
 
 Suffered from psychiatric illness 
 Pregnant 
 
STUDY PROCEDURES 
 
If you have agreed to participate in this study, you are required to sign the consent 
form.Then, you will be asked to fill up one form of questionnaire consisting of 
sociodemographic details,  diet,physical activity, alcohol consumption and nicotine 
dependence level.  After answering the questionnaire, you will be measured for 
BP,weight, height and waist circumference. The blood pressure will be taken 2 times 
during that time with each measurement will be 1 minute apart. Immediately  after that 
you will be informed the findings gathered from the questionnaire and physical 
examination. If any abnormal finding noted from this study you will be referred for 
further management . Then, your participation in this study is complete. 
 
RISKS 
 
There is no foreseeable risk or harm in participation of this study. 
PARTICIPATION IN THE STUDY 
 
Your taking part in this study is entirely voluntary.  You may refuse to take part in the 
study or you may stop participation in the study at anytime, without a penalty or loss of 
benefits to which you are otherwise entitled.   
 
 
POSSIBLE BENEFITS [Benefit to Individual, Community, University] 
 
From this study,you will know about your health status if not known before and early 
intervention can be done to reduce the risk noted from the questionnaire and physical 
examination from this study. We hope that the outcome and information regarding this 
research will be beneficial to future patients. 
 
QUESTIONS 
 
If you have any question about this study or your rights, please contact; 
 
Dr Nor Khairi Binti Deris (MMC: 41765) 
Jabatan Perubatan Keluarga 
Universiti Sains Malaysia 
USM Kampus Kesihatan 
Tel no : 017-9810028 
 
If you have any questions regarding the Ethical Approval or any issue / problem related 
to this study, please contact; 
 
 
 
 
Mr. Mohd Bazlan Hafidz Mukrim 
Secretary of Human Research Ethics Committee USM 
Centre for Research Initiatives, Clinical & Health Sciences 
USM Health Campus 
Tel. No. : 09-767 2354 / 09-767 2362 
Email : bazlan@usm.my/jepem@usm.my 
 
CONFIDENTIALITY 
 
Your medical information will be kept confidential by the study doctor and staff and 
will not be made publicly available unless disclosure is required by law. 
 
Data obtained from this study that does not identify you individually will be published 
for knowledge purposes. 
 
Your original medical records may be reviewed by the researcher, the Ethical Review 
Board for this study, and regulatory authorities for the purpose of verifying clinical trial 
procedures and/or data.  Your medical information may be held and processed on a 
computer. 
 
By signing this consent form, you authorize the record review, information storage and 
data transfer described above. 
 
 
SIGNATURES 
 
To be entered into the study, you or a legal representative must sign and data the 
signature page [ATTACHMENT S or ATTACHMENT P] 
 
 
ATTACHMENT S 
 
 
Patient/Subject Information and Consent Form 
(Signature Page) 
 
 
Research Title:  Prevalence of prehypertension  among smokers attending 
Klinik Kesihatan Bandar Kota Bharu and its associated 
factor  
 
Researcher’s Name :  Dr Nor Khairi Binti Deris (MMC: 41765) 
 Dr Nani Draman (MMC: 35488) 
 Dr Azlina Ishak (MMC: 37546) 
 
To become a part this study, you or your legal representative must sign this page. By 
signing this page, I am confirming the following: 
 
  I have read al l  of  the informat ion in  th is  Pat ient  Informat ion 
and Consent  Form including any information regarding the 
risk in  this  study and I have had t ime to think about  i t .  
  All  of  my quest ions have been answer ed to  my sat isfact ion.  
  I voluntari l y agree to  be part  of  this  research s tudy,  to  fol low 
the s tudy procedures ,  and to  provide necessary informat ion to  
the doctor ,  nurses ,  or  other  s taff  members ,  as  requested.  
  I may freely choose to  s top being a part  of  this  s tudy at  
anyt ime.  
  I have received a  copy of  this  Patient  Informat ion and 
Consent  Form to keep for  myself .  
 
 
 
 
Patient Name (Print or type)      Patient Initials and 
Number 
 
 
 
Patient I.C No. (New)       Patient I.C 
No. (Old) 
 
 
 
 
Signature of Patient or Legal Representative    Date 
(dd/MM/yy) 
(Add time if 
applicable) 
 
 
 
 
 
Name of Individual  
Conducting Consent Discussion (Print or Type) 
 
 
 
 
Signature of Individual       Date (dd/MM/yy) 
Conducting Consent Discussion   
 
 
 
 
Name & Signature of Witness                Date 
(dd/MM/yy) 
 
 
 
Note:  i) All subject/patients who are involved in this study will not be covered by 
insurance. 
  
 
 
ATTACHMENT P 
 
 
Patient’s Material Publication Consent Form 
Signature Page 
 
Research Title: Prevalence of prehypertension  among smokers attending 
Klinik Kesihatan Bandar Kota Bharu and its associated 
factor 
  
Researcher’s Name: Dr Nor Khairi Deris (MMC: 41765) 
 Dr Nani Draman (MMC: 35488) 
 Dr Azlina Ishak (MMC: 37546) 
 
To become a part this study, you or your legal representative must sign this page.  
By signing this page, I am confirming the following: 
 
 I understood that  my name wil l  not  appear on  the materia ls  
publ ished and there  has  been efforts  to  make sure that  the  
privacy of  my name is  kept  confident ial  al though the 
confident ial i ty is  not  completely guaranteed due to 
unexpected ci rcumstances.  
 I have read the materials or general description of what the 
material contains and reviewed all photographs and figures in 
which I am included that could be published.   
  I have been offered the opportunity to read the manuscript and to 
see all materials in which I am included, but have waived my 
right to do so.  
  All  the publ ished materials  wil l  be shared among the medical  
pract i t ioners ,  scient is ts  and journal is t  world wide.  
  The materials  wil l  also be used in  local  publ icat ions,  book 
publ icat ions and accessed by many local  and  internat ional  
doctors  world wide.  
  I hereby agree and  al low the material s  to  be used in  other  
publ icat ions required by other  publ ishers  with these 
condi t ions:  
  The materials  wil l  not  be used as  advert isement  purposes  nor 
as  packaging materials .  
  The materials  wil l  not  be used out  of  contex  –  i .e . :  Sample 
pictures  wil l  not  be used in  an art icle which is  unrelated  
subject  to  the picture.  
 
 
 
 
Patient Name (Print or type)     Patient Initials or Number 
 
 
 
 
 
 
Patient I.C No.   Patient’s Signature   Date (dd/MM/yy) 
 
 
 
 
 
Name and Signature of Individual     Date (dd/MM/yy) 
Conducting Consent Discussion  
 
Note:  i) All subject/patients who are involved in this study will not be covered by 
insurance 
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Nama Penyelidik: 
PENGENALAN 
LAMPIRAN A 
MAKLUMAT KAJIAN 
Prevalen prahipertensi dan faktor berkaitan prahipertensi di 
kalangan perokok yang hadir ke Klinik Kesihatan Bandar Kota 
Bharu 
Dr Nor Khairi Binti Deris (MMC: 41765) 
Dr Nani Draman (MMC: 35488) 
Dr Azlina Ishak (MMC: 37546) 
Anda dipelawa untuk menyertai secara sukarela dalam satu kajian penyelidikan 
mengenai prevalen prehipertensi dan faktor berkaitan prehipertensi di kalangan perokok 
yang hadir ke Klinik Kesihatan Kota Bharu. Prehipertensi adalah satu keadaan di mana 
tekanan darah sistolik pada kadar 120- 139mHg dan tekanan darah diastolik pada kadar 
80- 89mmHg di kalangan orang dewasa yang berumur 18 tahun dan ke atas. Mereka 
yang mengalami prehipertensi menghadapi risiko yang tinggi untuk mengidap penyakit 
hipertensi. Kedua-dua prehipertensi dan hipertensi adalah faktor risiko untuk penyakit 
kardiovaskular, angin ahmar dan_serangan jantung. Sebelum anda bersetuju untuk 
menyertai kajian penyelidikan ini, adalah penting anda membaca dan memahami borang 
ini. Sekiranya anda menyertai kajian ini, anda akan menerima satu salinan borang ini 
untuk disimpan sebagai rekod anda. 
Penyertaan anda di dalam kajian ini adalah dijangka mengambil masa selama 15 minit. 
Seramai 339 pesakit akan menyertai kajian ini. 
TUJUAN KAJIAN 
Tujuan kajian ini adalah untuk menentukan bilangan pesakit prehipertensi di kalangan 
perokok yang datang ke Klinik Kesihatan Bandar Kota Bharu yang dianggap sihat serta 
mengenalpasti faktor-faktor tertentu yang mempengaruhi tekanan darah. 
KELAYAKANPENYERTAAN 
Adalah penting anda memberi maklumat tentang diri anda dan menjawab soalan dalam 
soal selidik dengan jujur. Anda tidak seharusnya menyertai kajian ini sekiranya anda 
tidak memenuhi semua syarat kelayakan. 
Individu yang menyertai kajian ini adalah memenuhi kriteria berikut : 
• Berumur lebih daripada 18 tahun 
 
 
Anda tidak boleh menyertai kajian ini sekiranya : 
 Anda mengidap atau sedang dirawat untuk penyakit kronik seperti darah tinggi, 
kencing manis, penyakit jantung, kegagalan buah pinggang dan angin ahmar. 
 Anda sedang mengandung 
 Mengalami masalah psikiatri 
 
PROSEDUR-PROSEDUR KAJIAN 
Sekiranya anda bersetuju menyertai kajian ini, anda akan diminta untuk 
menandatangani surat kebenaran untuk menyertai kajian ini. Kemudian anda 
dikehendaki mengisi satu borang soal jawab yang mengandungi soalan berkaitan latar 
belakang sosio demografik anda, diet, aktiviti fizikal, pengambilan alkohol dan tahap 
ketagihan nikotin. Selepas selesai menjawab soalan, anda akan diukur untuk tekanan 
darah,berat,tinggi dan lilit pinggang dan tekanan darah. Bacaan tekanan darah anda 
akan di ambil sebanyak dua kali dalam selang 1 minit. Selepas selesai 
pemeriksaan,penyelidik akan memberitahu penemuan yang diperolehi dari kajian 
ini.Sekiranya terdapat penemuan yang tidak normal, anda akan dirujuk untuk tindakan 
seterusnya dan penyertaan anda dalam kajian ini selesai. 
 
RISIKO 
Tidak ada sebarang risiko yang terlibat dalam kajian ini. 
 
PENYERTAAN DALAM KAJIAN 
Penyertaan anda dalam kajian ini adalah secara sukarela. Anda berhak menolak untuk 
menyertai kajian ini tanpa sebarang hukuman atau kehilangan manfaat yang sepatutnya 
anda perolehi. 
 
MANFAAT YANG MUNGKIN [Manfaat terhadap Individu, Masyarakat, 
Universiti] 
Penyertaan anda dalam kajian ini adalah secara sukarela. Melalui kajian ini, anda dapat 
mengetahui status kesihatan anda dan intervensi awal dapat dilakukan untuk 
mengurangkan faktor risiko.Selain itu,penyertaan anda dalam kajian ini akan membantu 
kami untuk memahami dengan lebih lanjut tentang kaitan prehipertensi di kalangan 
perokok dan maklumat tersebut dapat digunakan untuk merawat pesakit lain kemudian 
hari. 
 
PERSOALAN 
Sekiranya anda mempunyai sebarang soalan mengenai prosedur kajian ini atau hak-hak 
anda, sila hubungi; 
Dr Nor Khairi Binti Deris (MMC: 41765) 
Jabatan Perubatan Keluarga 
Universiti Sains Malaysia 
USM Kampus Kesihatan 
No Tel :017-9810028 
 
 
Sekiranya anda mempunyai sebarang soalan berkaitan kelulusan Etika atau sebarang 
pertanyaan dan masalah berkaitan kajian ini, sila hubungi; 
 
   En. Mohd Bazlan Hafidz Mukrim 
Setiausaha Jawatankuasa Etika Penyelidikan (Manusia)       
USM 
Pusat Inisiatif Penyelidikan -Sains Klinikal & Kesihatan 
USM Kampus Kesihatan. 
No. Tel: 09-767 2354 / 09-767 2362 
Email : bazlan@usm.my/jepem@usm.my 
 
 
KERAHSIAAN 
 
Maklumat perubatan anda akan dirahsiakan oleh doktor dan kakitangan kajian. Ianya 
tidak akan dedahkan secara umum melainkan jika ia dikehendaki oleh undang-undang. 
 
Data yang diperolehi dari kajian yang tidak mengenalpasti anda secara perseorangan 
mungkin akan diterbitkan untuk tujuan memberi pengetahuan baru. 
 
Rekod perubatan anda yang asal mungkin akan dilihat oleh pihak penyelidik, Lembaga 
Etika kajian ini dan pihak berkuasa regulatori untuk tujuan mengesahkan prosedur 
dan/atau data kajian klinikal.  Maklumat perubatan anda mungkin akan disimpan dalam 
komputer dan diproses dengannya. 
 
Dengan menandatangani borang persetujuan ini, anda membenarkan penelitian rekod, 
penyimpanan maklumat dan pemindahan data seperti yang dihuraikan di atas. 
 
TANDATANGAN 
 
Untuk dimasukkan ke dalam kajian ini, anda atau wakil sah anda mesti menandatangani 
serta mencatatkan tarikh halaman tandatangan (Borang Keizinan Pesakit di 
LAMPIRAN S  dan LAMPIRAN P). 
 
 
LAMPIRAN S 
 
 
Borang Keizinan Pesakit/ Subjek 
(Halaman Tandatangan) 
 
Tajuk Kajian: Prevalen prahipertensi dan faktor berkaitan prahipertensi di 
kalangan perokok yang hadir ke Klinik Kesihatan Bandar Kota 
Bharu 
 
 
Nama Penyelidik:  Dr Nor Khairi Deris (MMC: 41765) 
   Dr Nani Draman (MMC: 35488) 
   Dr Azlina Ishak (MMC:37546) 
    
Untuk menyertai kajian ini, anda atau wakil sah anda mesti menandatangani mukasurat 
ini. Dengan menandatangani mukasurat ini, saya mengesahkan yang berikut: 
 
  Saya telah membaca semua maklumat  dalam Borang 
Maklumat  dan Keiz inan Pesaki t  ini  termasuk apa-apa 
maklumat berkaitan ris iko yang ada da lam kajian  dan  saya  
telah pun diberi  masa yang mencukupi  untuk 
mempert imbangkan maklumat  tersebut .  
  Semua soalan-soalan saya  telah di jawab dengan memuaskan.  
  Saya,  secara sukarela,  bersetuju  menyertai  kaj ian 
penyel idikan ini ,  mematuhi  segala prosedur kaj ian dan 
memberi  maklumat  yang diperlukan kepada doktor ,  para  
jururawat  dan juga  kaki tangan lain yang berkai tan apabi la 
diminta.  
  Saya boleh menamatkan penyertaan saya  dalam kaj ian ini  
pada bi la-bi la  masa.  
  Saya telah pun menerima satu sal inan Borang Maklumat  dan  
Keiz inan Pesaki t  untuk s impanan peribadi  saya.  
 
 
 
 
Nama Pesakit (Dicetak atau Ditaip)    Nama Singkatan & No. 
Pesakit 
 
 
 
 
No. Kad Pengenalan Pesakit (Baru)   No. K/P (Lama) 
 
 
 
 
 
 
 
 
Tandatangan Pesakit atau Wakil Sah    Tarikh (dd/MM/yy) 
(Masa jika perlu) 
 
 
 
 
 
Nama & Tandatangan  Individu yang Mengendalikan    Tarikh (dd/MM/yy) 
Perbincangan Keizinan (Dicetak atau Ditaip) 
 
 
 
 
 
 
Nama Saksi dan Tandatangan     Tarikh (dd/MM/yy) 
 
 
 
Nota: i) Semua subjek/pesakit yang mengambil bahagian dalam projek penyelidikan 
ini tidak dilindungi insuran. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Borang Keizinan bagi Penerbitan Bahan yang berkaitan dengan Pesakit/ 
Subjek 
(Halaman Tandatangan) 
 
Tajuk Kajian : Prevalen prahipertensi dan faktor berkaitan prahipertensi di 
kalangan perokok yang hadir ke Klinik Kesihatan Bandar Kota 
Bharu 
 
Nama Penyelidik :  Dr Nor Khairi Deris (MMC: 41765) 
   Dr Nani Draman (MMC: 35488) 
   Dr Azlina Ishak (MMC:37546) 
    
Untuk menyertai kajian ini, anda atau wakil sah anda mesti menandatangani mukasurat ini.  
 
Dengan menandatangani mukasurat ini, saya memahami yang berikut: 
 
  Bahan yang akan d i t e rb i tkan tanpa d i lam pi rkan dengan nam a saya 
dan  se t iap  percubaan yang akan d ibuat  un tuk  m em ast ikan 
ke tanpanam aan sa ya.  Saya  m em aham i ,  wa laubaga im anapun,  
ke tanpanam aan yang sem purna t i dak  dapat  d i j am in .  Kem ungk inan 
ses iapa yang m enjaga sa ya d i  hosp i ta l  a tau  saudara  dapat  
m engena l i  saya .  
  Bahan yang akan d i te rb i tkan da lam  penerb i tan  
m ingguan/bu lanan/dw ibu lanan/suku tahunan/dwi  t ahunan 
m erupakan sa tu  penyebaran yang l uas  dan te rsebar  ke  se luruh 
dun ia .  Keban yakan penerb i tan  in i  akan te rsebar  kepada dok tor -
dok tor  dan juga bukan dok tor  te rm asuk  ah l i  sa ins  dan  ah l i  j u rna l .  
  Bahan te rsebut  j uga akan d i lam pi rkan pada lam an web ju rna l  d i  
se lu ruh  dun ia .  Sesetengah lam an web  in i  bebas  d ikun jung i  o leh  
sem ua orang .  
  Bahan te rsebut  j uga akan d igunakan sebaga i  penerb i tan  tem patan 
dan d isam paikan o leh  ram ai  dok tor  dan  ah l i  sa ins  d i  se luruh 
dun ia .  
  Bahan te rsebu t  j uga  akan d igunakan sebaga i  penerb i tan  buku 
o leh  penerb i t  j u rna l .  
  Bahan te r sebut  t idak  akan d igunakan untuk  peng ik lanan a taupun  
bahan untuk  m em bungkus .  
 
Sa ya juga m em ber i  ke iz inan bahawa bahan te rsebu t  bo leh  d igunakan 
sebaga i  penerb i tan  la in  yang d im in ta  o leh  penerb i t  dengan  k r i te r ia  ber iku t :  
 
  Bahan te rsebut  t idak  akan d igunakan untuk  peng ik lanan a tau 
bahan untuk  m em bungkus .  
  Bahan te rsebut  t idak  akan d igunakan d i  luar  konteks  –  contohnya :  
Gam bar  t idak  akan d igunakan untuk  m enggam barkan sesuatu  
ar t ike l  yang t idak  berka i tan  dengan sub jek  da lam  fo to  te rsebut .  
 
 
 
 
Nama Pesakit (Dicetak atau Ditaip)    Nama Singkatan atau No. 
Pesakit 
 
 
 
 
 
 
 
No. Kad Pengenalan Pesakit  T/tangan Pesakit  Tarikh (dd/MM/yy) 
 
 
 
 
 
Nama & Tandatangan  Individu yang Mengendalikan    Tarikh (dd/MM/yy) 
Perbincangan Keizinan (Dicetak atau Ditaip) 
 
 
 
Nota: i) Semua subjek/pesakit yang mengambil bahagian dalam projek penyelidikan ini tidak dilindungi insuran. 
 
 
 
 
